Atorvastatin accelerates Mycobacterium tuberculosis clearance in pulmonary TB: a randomised phase IIA trial

Saved in:
Bibliographic Details
Published inThe international journal of tuberculosis and lung disease Vol. 27; no. 3; pp. 226 - 228
Main Authors Adewole, O. O., Omotoso, B. A., Ogunsina, M., Aminu, A., Odeyemi, A. O., Awopeju, O. F., Ayoola, O., Adedeji, T., Sogaolu, O. M., Adewole, T. O., Jiya, E., Andero, V., Obaseki, D., Akintomide, A. O., Erhabor, G. E.
Format Journal Article
LanguageEnglish
Published France International Union Against Tuberculosis and Lung Disease 01.03.2023
International Union against Tuberculosis and Lung Disease (IUATLD)
Subjects
Atorvastatin
Atorvastatin - adverse effects
Humans
Mycobacterium tuberculosis
Tuberculosis
Tuberculosis, Pulmonary - drug therapy
Online AccessGet full text

Cover

More Information
Bibliography:1027-3719(20230301)27:3L.226;1-
(R) Medicine - General
SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Feature-1
ObjectType-Correspondence-3
ObjectType-Undefined-4
ISSN:1027-3719
1815-7920
DOI:10.5588/ijtld.22.0548